Erratum: Prolonged nerve blockade delays the onset of neuropathic pain (Proceedings of the National Academy of Sciences of the United States of America (2012) 109 (17555-17560) DOI: 10.1073/pnas.1214634109);Prolonged nerve blockade delays the onset of neuropathic pain

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 43, 2012, Pages 17555-17560

  Shankarappa, Sahadev A ^a,b   Tsui, Jonathan H ^a,b   Kim, Kristine N ^a   Reznor, Gally ^a   Dohlman, Jenny C ^a   Langer, Robert ^b   Kohane, Daniel S ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Conduction block; Drug delivery; Hyperalgesia; Prolonged anesthesia

Indexed keywords

DEXAMETHASONE; LIPOSOME; SAXITOXIN;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CELL ACTIVATION; CONTROLLED STUDY; DRUG FORMULATION; GENE EXPRESSION; NERVE BLOCK; NERVE CONDUCTION; NERVE INJURY; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; RAT; SCIATIC NERVE; SINGLE DRUG DOSE; SPINAL CORD DORSAL HORN; SPINAL GANGLION; TREATMENT DURATION;

EID: 84867911567     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1306394110     Document Type: Erratum

References (57)

1. (1986) Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Prepared by the International Association for the Study of Pain, Subcommittee on Taxonomy. Pain Suppl 3:S1-S226.
2. Zimmermann M (2001) Pathobiology of neuropathic pain. Eur J Pharmacol 429:23-37.
3. Harden RN (2005) Chronic neuropathic pain. Mechanisms, diagnosis, and treatment. Neurologist 11:111-122.
4. Turk DC (2002) Clinical effectiveness and cost-effectiveness of treatments for patients with chronic pain. Clin J Pain 18:355-365.
5. Wu G, et al. (2001) Early onset of spontaneous activity in uninjured C-fiber nociceptors after injury to neighboring nerve fibers. J Neurosci 21:RC140.
6. Govrin-Lippmann R, Devor M (1978) Ongoing activity in severed nerves: Source and variation with time. Brain Res 159:406-410. (Pubitemid 9050975)
7. Wall PD, Devor M (1983) Sensory afferent impulses originate from dorsal root ganglia as well as from the periphery in normal and nerve injured rats. Pain 17:321-339. (Pubitemid 14211848)
8. Coggeshall RE, Lekan HA, White FA, Woolf CJ (2001) A-fiber sensory input induces neuronal cell death in the dorsal horn of the adult rat spinal cord. J Comp Neurol 435:276-282. (Pubitemid 32523645)
9. Choi DW (1994) Calcium and excitotoxic neuronal injury. Ann N Y Acad Sci 747:162-171.
10. Woolf CJ, Salter MW (2000) Neuronal plasticity: Increasing the gain in pain. Science 288:1765-1769.
11. Dougherty PM, Garrison CJ, Carlton SM (1992) Differential influence of local anesthetic upon two models of experimentally induced peripheral mononeuropathy in the rat. Brain Res 570:109-115.
12. Sotgiu ML, Castagna A, Lacerenza M, Marchettini P (1995) Pre-injury lidocaine treatment prevents thermal hyperalgesia and cutaneous thermal abnormalities in a rat model of peripheral neuropathy. Pain 61:3-10.
13. Xie W, Strong JA, Zhang JM (2009) Early blockade of injured primary sensory afferents reduces glial cell activation in two rat neuropathic pain models. Neuroscience 160:847-857.
14. Xie W, Strong JA, Meij JTA, Zhang J-M, Yu L (2005) Neuropathic pain: Early spontaneous afferent activity is the trigger. Pain 116:243-256. (Pubitemid 40957128)
15. Suter MR, et al. (2003) Development of neuropathic pain in the rat spared nerve injury model is not prevented by a peripheral nerve block. Anesthesiology 99:1402-1408. (Pubitemid 37475188)
16. Scholz J, et al. (2005) Blocking caspase activity prevents transsynaptic neuronal apoptosis and the loss of inhibition in lamina II of the dorsal horn after peripheral nerve injury. J Neurosci 25:7317-7323. (Pubitemid 41129803)
17. Wen Y-R, et al. (2007) Nerve conduction blockade in the sciatic nerve prevents but does not reverse the activation of p38 mitogen-activated protein kinase in spinal microglia in the rat spared nerve injury model. Anesthesiology 107:312-321. (Pubitemid 47196496)
18. Seltzer Z, Cohn S, Ginzburg R, Beilin B (1991) Modulation of neuropathic pain behavior in rats by spinal disinhibition and NMDA receptor blockade of injury discharge. Pain 45:69-75.
19. Yoon YW, Na HS, Chung JM (1996) Contributions of injured and intact afferents to neuropathic pain in an experimental rat model. Pain 64:27-36. (Pubitemid 26062244)
20. Padera RF, Tse JY, Bellas E, Kohane DS (2006) Tetrodotoxin for prolonged local anesthesia with minimal myotoxicity. Muscle Nerve 34:747-753. (Pubitemid 44877558)
21. Kohane DS, Langer R (2010) Biocompatibility and drug delivery systems. Chem Sci 1:441-446.
22. Kohane DS, et al. (2000) The local anesthetic properties and toxicity of saxitonin homologues for rat sciatic nerve block in vivo. Reg Anesth Pain Med 25:52-59.
23. Zhang M-M, et al. (2010) Cooccupancy of the outer vestibule of voltage-gated sodium channels by micro-conotoxin KIIIA and saxitoxin or tetrodotoxin. J Neurophysiol 104:88-97.
24. Curley J, et al. (1996) Prolonged regional nerve blockade. Injectable biodegradable bupivacaine/polyester microspheres. Anesthesiology 84:1401-1410. (Pubitemid 26192049)
25. Kohane DS, et al. (2003) Prolonged duration local anesthesia from tetrodotoxin-enhanced local anesthetic microspheres. Pain 104:415-421. (Pubitemid 36835909)
26. Epstein-Barash H, et al. (2009) Prolonged duration local anesthesia with minimal toxicity. Proc Natl Acad Sci USA 106:7125-7130.
27. Colombo G, Padera R, Langer R, Kohane DS (2005) Prolonged duration local anesthesia with lipid-protein-sugar particles containing bupivacaine and dexamethasone. J Biomed Mater Res A 75:458-464. (Pubitemid 41463915)
28. Gold MS, Reichling DB, Hampl KF, Drasner K, Levine JD (1998) Lidocaine toxicity in primary afferent neurons from the rat. J Pharmacol Exp Ther 285:413-421. (Pubitemid 28237413)
29. Radwan IAM, Saito S, Goto F (2002) The neurotoxicity of local anesthetics on growing neurons: A comparative study of lidocaine, bupivacaine, mepivacaine, and ropivacaine. Anesth Analg 94:319-324. (Pubitemid 34106821)
30. Padera R, Bellas E, Tse JY, Hao D, Kohane DS (2008) Local myotoxicity from sustained release of bupivacaine from microparticles. Anesthesiology 108:921-928. (Pubitemid 351589489)
31. Kohane DS, et al. (2002) Biocompatibility of lipid-protein-sugar particles containing bupivacaine in the epineurium. J Biomed Mater Res 59:450-459. (Pubitemid 34037488)
32. Wieseler-Frank J, Maier SF, Watkins LR (2004) Glial activation and pathological pain. Neurochem Int 45:389-395. (Pubitemid 38625629)
33. Blackbeard J, et al. (2007) Quantification of the rat spinal microglial response to peripheral nerve injury as revealed by immunohistochemical image analysis and flow cytometry. J Neurosci Methods 164:207-217. (Pubitemid 47018274)
34. Guo W, et al. (2007) Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain. J Neurosci 27:6006-6018. (Pubitemid 46849761)
35. Costigan M, et al. (2002) Replicate high-density rat genome oligonucleotide microarrays reveal hundreds of regulated genes in the dorsal root ganglion after peripheral nerve injury. BMC Neurosci 3:16.
36. Wang H, et al. (2002) Chronic neuropathic pain is accompanied by global changes in gene expression and shares pathobiology with neurodegenerative diseases. Neuroscience 114:529-546. (Pubitemid 35247642)
37. Roza C, Laird JMA, Souslova V, Wood JN, Cervero F (2003) The tetrodotoxin-resistant Na+ channel Nav1.8 is essential for the expression of spontaneous activity in damaged sensory axons of mice. J Physiol 550:921-926. (Pubitemid 37010074)
38. Han HC, Lee DH, Chung JM (2000) Characteristics of ectopic discharges in a rat neuropathic pain model. Pain 84:253-261.
39. Gao YJ, Ji RR (2010) Chemokines, neuronal-glial interactions, and central processing of neuropathic pain. Pharmacol Ther 126:56-68.
40. Tamargo RJ, Epstein JI, Reinhard CS, Chasin M, Brem H (1989) Brain biocompatibility of a biodegradable, controlled-release polymer in rats. J Biomed Mater Res 23:253-266. (Pubitemid 19042070)
41. Kopacz DJ, et al. (2003) The dose response and effects of dexamethasone on bupivacaine microcapsules for intercostal blockade (T9 to T11) in healthy volunteers. Anesth Analg 96:576-582. (Pubitemid 36125785)
42. Kohane DS (2007) Microparticles and nanoparticles for drug delivery. Biotechnol Bioeng 96:203-209.
43. Kohane DS, Lipp M, Kinney RC, Lotan N, Langer R (2000) Sciatic nerve blockade with lipid-protein-sugar particles containing bupivacaine. Pharm Res 17:1243-1249.
44. Rose JS, Neal JM, Kopacz DJ (2005) Extended-duration analgesia: Update on microspheres and liposomes. Reg Anesth Pain Med 30:275-285. (Pubitemid 40718910)
45. Kuzma PJ, Kline MD, Calkins MD, Staats PS (1997) Progress in the development of ultra-long-acting local anesthetics. Reg Anesth 22:543-551. (Pubitemid 28008142)
46. Suzuki R, Dickenson AH (2006) Differential pharmacological modulation of the spontaneous stimulus-independent activity in the rat spinal cord following peripheral nerve injury. Exp Neurol 198:72-80. (Pubitemid 43243746)
47. Erichsen HK, Blackburn-Munro G (2002) Pharmacological characterisation of the spared nerve injury model of neuropathic pain. Pain 98:151-161. (Pubitemid 34722477)
48. Kim SH, Chung JM (1992) An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50:355-363.
49. Seltzer Z, Dubner R, Shir Y (1990) A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 43:205-218. (Pubitemid 20385185)
50. Takaishi K, Eisele JH, Jr., Carstens E (1996) Behavioral and electrophysiological assessment of hyperalgesia and changes in dorsal horn responses following partial sciatic nerve ligation in rats. Pain 66:297-306. (Pubitemid 26284000)
51. Yasuda T, Miki S, Yoshinaga N, Senba E (2005) Effects of amitriptyline and gabapentin on bilateral hyperalgesia observed in an animal model of unilateral axotomy. Pain 115:161-170.
52. Decosterd I, Woolf CJ (2000) Spared nerve injury: An animal model of persistent peripheral neuropathic pain. Pain 87:149-158. (Pubitemid 30621447)
53. Broom DC, et al. (2004) Cyclooxygenase 2 expression in the spared nerve injury model of neuropathic pain. Neuroscience 124:891-900. (Pubitemid 38328778)
54. Koltzenburg M, Wall PD, McMahon SB (1999) Does the right side know what the left is doing? Trends Neurosci 22:122-127. (Pubitemid 29151805)
55. Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911-917.
56. Bates HA, Kostriken R, Rapoport H (1978) A chemical assay for saxitoxin. Improvements and modifications. J Agric Food Chem 26:252-254.
57. Shankarappa SA, Piedras-Rentería ES, Stubbs EB, Jr. (2011) Forced-exercise delays neuropathic pain in experimental diabetes: Effects on voltage-activated calcium channels. J Neurochem 118:224-236.